Invasive mucormycosis during treatment for acute lymphoblastic leukaemia—successful management of two life-threatening diseases

A 5-year-old patient treated for acute lymphoblastic leukaemia (ALL) developed proven pulmonary invasive fungal disease (IFD) due to Actinomucor elegans. While completing ALL treatment according to AIEOP ALL protocol 2009 for further 15 months, antifungal treatment with liposomal amphotericin B and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Support Care Cancer
Päätekijät: Trobisch, Andreas, Marterer, R., Gorkiewicz, G., Flaschberger, S., Lackner, H., Seidel, M., Sperl, D., Karastaneva, A., Kohlmaier, B., Egger, M., Urban, C., Benesch, M., Strenger, V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7083803/
https://ncbi.nlm.nih.gov/pubmed/31410599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-04962-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia